Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aluminum chloride gel versus phenylephrine drops for idiopathic anterior epistaxis
IRCT20180129038549N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of aluminum chloride and phenylephrine in epistaxis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Bleeding control time and Bleeding stopped within 10 minutes. Started Aug 2017; status: completed.
02
Drugs
aluminum chloridephenylephrine
03
Conditions
epistaxis
Beyond the preview
Go deeper on IRCT20180129038549N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180129038549N6.